Fast Neutron Radiotherapy for Sarcomas of the Bone and Soft Tissue
It has been generally accepted that sarcomas of the bone and soft tissue are radioresistant compared with other tumors, such as squamous cell carcinoma and adenocarcinoma. Therefore, patients with sarcoma of the bone and soft tissue have been usually referred to radiation therapy after removal of the tumor in order to manage residual tumor cells. On the other hand, there is support for the role of preoperative irradiation for those sarcomas in order to preserve function of the involved extremities.
KeywordsSoft Tissue Sarcoma Fast Neutron Synovial Sarcoma Preoperative Irradiation Local Control Rate
Unable to display preview. Download preview PDF.
- 1.Tsunemoto H, Morita S, Arai T, Kutsutani Y, Kurisu A, Umegaki Y (1979) Results of clinical trials with 30MeV d-Be neutrons at NIRS. In: Abe M (eds) Treatment of radio-resistant cancers. Elsevier, North Holland, pp 115–126Google Scholar
- 2.Tatezaki S (1979) Systemic multi-modal treatment of osteosarcoma, with special reference to the role of fast neutron radiotherapy, J Jpn Orthop Assoc 53: 831–846Google Scholar
- 3.Wambersie A (1989) The future of high LET radiation in cancer therapy. Justification of the heavy-ion therapy program. In: Chaubel P (ed) Proceedings of the EULIMA Workshop on the Potential Value of Light Ion Beam Therapy (CAL edn). Commission of the European Communities, Brussels, Publn. No. EUR 12165 EN, pp XIX—LIIIGoogle Scholar